Skip to main content

Table 1 Cytotoxicity of drugs in A549/DDP and A549/MDR cells

From: Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells

Drug A549/DDP IC50 (μg/ml) A549/MDR IC50 (μg/ml) RI
5-fluorouracil 28.17 130.06 4.62
Paclitaxel 4.65 82.82 17.83
Mitomycin 1.43 8.67 6.04
Vinorelbine Tartrate 6.09 12.39 2.04
Cisplatin 5.00 33.51 6.70
Gemcitabine Hydrochloride 1.08 19.01 17.59
  1. IC50 50% inhibitory concentration, RI resistance index, DDP Cisplatin, MDR multidrug resistance